Skip to menu Skip to content Skip to footer

2013

Conference Publication

Association of IFNL3 polymorphisms with fibrosis progression in viral and non-viral chronic liver disease

Eslam, M., Leung, R., Berg, T., Irving, W. L., Mangia, A., Sheridan, D., Abate, M. L., Weltman, M., Spengler, U., Mollison, L., Cheng, W., Dore, G. J., Powell, E., Riordan, S., Douglas, M., Suppiah, V., Stewart, G. J., Booth, D. R., George, J. and Ahlenstiel, G. (2013). Association of IFNL3 polymorphisms with fibrosis progression in viral and non-viral chronic liver disease. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_5

Association of IFNL3 polymorphisms with fibrosis progression in viral and non-viral chronic liver disease

2013

Conference Publication

BMI but not aetiology or stage of liver disease affects the diagnostic sensitivity of carbohydrate deficient transferrin

Fagan, K., Irvine, K., McWhinney, B., Fletcher, L., Horsfall, L., Johnson, L., Clouston, A., Jonsson, J., O'Rourke, P., Martin, J., Pretorius, C., Ungerer, J. and Powell, E. (2013). BMI but not aetiology or stage of liver disease affects the diagnostic sensitivity of carbohydrate deficient transferrin. International Liver Congress / 48th Annual Meeting of the European Association for the Study of the Liver (EASL), Amsterdam, Netherlands, 24-28 April 2013. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(13)60527-9

BMI but not aetiology or stage of liver disease affects the diagnostic sensitivity of carbohydrate deficient transferrin

2012

Journal Article

Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

Patin, Etienne, Kutalik, Zoltan, Guergnon, Julien, Bibert, Stephanie, Nalpas, Bertrand, Jouanguy, Emmanuelle, Munteanu, Mona, Bousquet, Laurence, Argiro, Laurent, Halfon, Philippe, Boland, Anne, Muellhaupt, Beat, Semela, David, Dufour, Jean-Francois, Heim, Markus H., Moradpour, Darius, Cerny, Andreas, Malinverni, Raffaele, Hirsch, Hans, Martinetti, Gladys, Suppiah, Vijayaprakash, Stewart, Graeme, Booth, David R., George, Jacob, Casanova, Jean-Laurent, Brechot, Christian, Rice, Charles M., Talal, Andrew H., Jacobson, Ira M. ... French ANRS HC EP 26 Genoscan Study Group (2012). Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection. Gastroenterology, 143 (5), 1244-+. doi: 10.1053/j.gastro.2012.07.097

Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

2012

Journal Article

Liver repercussions of defective gut surveillance

Irvine, Katharine M., Schroder, Elizabeth E. and Powell, Elizabeth E. (2012). Liver repercussions of defective gut surveillance. Hepatology, 56 (3), 1174-1177. doi: 10.1002/hep.25944

Liver repercussions of defective gut surveillance

2012

Journal Article

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

Melino, Michelle, Gadd, Victoria L., Walker, Gene V., Skoien, Richard, Barrie, Helen D., Jothimani, Dinesh, Horsfall, Leigh, Jones, Alun, Sweet, Matthew J., Thomas, Gethin P., Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2012). Macrophage secretory products induce an inflammatory phenotype in hepatocytes. World Journal of Gastroenterology, 18 (15), 1732-1744. doi: 10.3748/wjg.v18.i15.1732

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

2012

Conference Publication

A simple scoring system accurately excludes portal fibrosis in non-alcoholic fatty liver disease

Skoien, R., Rich, G. G., Horsfall, L., Jonsson, J. R., Clouston, A. D., George, J. and Powell, E. E. (2012). A simple scoring system accurately excludes portal fibrosis in non-alcoholic fatty liver disease. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, Spain, 18-22 April 2012. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(12)61081-2

A simple scoring system accurately excludes portal fibrosis in non-alcoholic fatty liver disease

2012

Conference Publication

Attitudes towards non-alcoholic fatty liver disease amongst non-hepatology specialists in two major Australian hospitals

Bergqvist, C. J., Skoien, R., Horsfall, L., Jonsson, J. R. and Powell, E. E. (2012). Attitudes towards non-alcoholic fatty liver disease amongst non-hepatology specialists in two major Australian hospitals. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, Spain, 18-22 April 2012. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(12)61333-6

Attitudes towards non-alcoholic fatty liver disease amongst non-hepatology specialists in two major Australian hospitals

2012

Conference Publication

CDT as a biomarker of alcohol excess in patients with chronic liver disease: BMI affects diagnostic sensitivity

Fagan, Kevin, McWhinney, Brett, Horsfall, Leigh, Ungerer, Jacobus P., Pretorius, Carel J., Johnson, Lambro A., Clouston, Andrew, Fletcher, Linda M., Jonsson, Julie, O'Rourke, Peter and Powell, Elizabeth (2012). CDT as a biomarker of alcohol excess in patients with chronic liver disease: BMI affects diagnostic sensitivity. Australian Gastroenterology Week 2012, Adelaide, SA Australia, 16-19 October 2012. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_5.x

CDT as a biomarker of alcohol excess in patients with chronic liver disease: BMI affects diagnostic sensitivity

2012

Journal Article

Triage of referrals to outpatient hepatology services: an ineffective tool to prioritise patients?

Horsfall, Leigh, Skoien, Richard, Moss, Cathy, Scott, Ian, Macdonald, Graeme A. and Powell, Elizabeth E. (2012). Triage of referrals to outpatient hepatology services: an ineffective tool to prioritise patients?. Australian Health Review, 36 (4), 443-447. doi: 10.1071/AH11111

Triage of referrals to outpatient hepatology services: an ineffective tool to prioritise patients?

2011

Journal Article

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study

Suppiah, Vijayaprakash, Gaudieri, Silvana, Armstrong, Nicola J., O'Connor, Kate S., Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Dore, Gregory J., Irving, William L., Powell, Elizabeth, Hellard, Margaret, Riordan, Stephen, Matthews, Gail, Sheridan, David, Nattermann, Jacob, Smedile, Antonina, Muller, Tobias, Hammond, Emma, Dunn, David, Negro, Francesco, Bochud, Pierre-Yves, Mallal, Simon, Ahlenstiel, Golo, Stewart, Graeme J., George, Jacob, Booth, David R. and for the International Hepatitis C Genetics Consortium (IHCGC) (2011). IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study. PLoS Medicine, 8 (9) e1001092, e1001092.1-e1001092.8. doi: 10.1371/journal.pmed.1001092

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study

2011

Journal Article

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

Smith, Katherine R., Suppiah, Vijayaprakash, O'Connor, Kate, Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Matthews, Gail, Irving, William L., Powell, Elizabeth, Riordan, Stephen, Ahlenstiel, Golo, Stewart, Graeme J., Bahlo, Melanie, George, Jacob and Booth, David R. (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3 (8) 57. doi: 10.1186/gm273

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

2011

Journal Article

Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

Moschen, Alexander R., Fritz, Teresa Fritz, Clouston, Andrew D., Rebhan, Ilka, Bauhofer, Oliver, Barrie, Helen D., Powell, Elizabeth E., Kim, Soo-Hyun, Dinarello, Charles A., Bartenschlager, Ralf, Jonsson, Julie R. and Tilg, Herbert (2011). Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology, 53 (6), 1819-1829. doi: 10.1002/hep.24285

Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

2011

Journal Article

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection

McPherson, Stuart, Powell, Elizabeth E., Barrie, Helen D., Clouston, Andrew D., McGuckin, Michael and Jonsson, Julie R. (2011). No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatalogy, 26 (2), 319-327. doi: 10.1111/j.1440-1746.2010.06368.x

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection

2011

Journal Article

Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?

Powell, Elizabeth E., Jonsson, Julie R. and Clouston, Andrew D. (2011). Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?. Gut, 60 (1), 1-2. doi: 10.1136/gut.2010.226365

Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?

2011

Journal Article

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism

Barclay, JL, Nelson, CN, Ishikawa, M, Murray, LA, Kerr, LM, McPhee, TR, Powell, EE and Waters, MJ (2011). GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology, 152 (1), 181-192. doi: 10.1210/en.2010-0537

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism

2011

Conference Publication

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

Melino, Michelle, Gadd, Victoria L., Thomas, G. P., Walker, Gene V., Skoien, Richard, Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2011). Macrophage secretory products induce an inflammatory phenotype in hepatocytes. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL.

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

2011

Conference Publication

Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis

Gadd, V.L., Roy, S., Clouston, A. D., Melino, M., Jonsson, J. R. and Powell, E. E. (2011). Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL.

Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis

2010

Conference Publication

Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis

Skoien, R., Powell, E. E., Melino, M., Clouston, A. D., Gabrielli, B. G. and Jonsson, J. R. (2010). Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis. Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/j.1440-1746.2010.06450.x

Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis

2010

Conference Publication

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

Powell, Elizabeth E., Jonsson, Julie R. and Clouston, Andrew D. (2010). Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Falk Symposium 171 on Liver and Metabolic Syndrome, Hannover, Germany, 15-18 October 2009. Basel, Switzerland: S. Karger AG. doi: 10.1159/000282084

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

2010

Conference Publication

Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis

Melino, M., Powell, E. E., Gadd, V. L., Skoien, R., Walker, G., Clouston, A. D. and Jonsson, J. R. (2010). Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis. AGW2010: Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October, 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06450.x

Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis